| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |